BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18348245)

  • 21. Physician Withdrawal Checklist (PWC-20).
    Rickels K; Garcia-Espana F; Mandos LA; Case GW
    J Clin Psychopharmacol; 2008 Aug; 28(4):447-51. PubMed ID: 18626273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin treatment of anxiety in patients with substance use disorders.
    Raza S; Siddiqui UA; Megna JL; Schwartz TL; Batki SL
    Ann Pharmacother; 2010 May; 44(5):937-8. PubMed ID: 20388860
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
    Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
    Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychiatric problems in therapy with benzodiazepines].
    Linder M
    Schweiz Med Wochenschr; 1983 May; 113(18):654-8. PubMed ID: 6135254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin in the treatment of alcohol and benzodiazepines dependence.
    Oulis P; Konstantakopoulos G
    CNS Neurosci Ther; 2010; 16(1):45-50. PubMed ID: 20070788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term anxiolytic therapy: the issue of drug withdrawal.
    Lader M
    J Clin Psychiatry; 1987 Dec; 48 Suppl():12-6. PubMed ID: 2891684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
    Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
    Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
    Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
    Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
    Hadley SJ; Mandel FS; Schweizer E
    J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
    Kornowski J
    Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The withdrawal syndrome in benzodiazepine dependence and its management].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.